Carolyn Haggerty
Bioscience Research(US)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Protein Degradation and Inhibitors, Computational Drug Discovery Methods, Synthesis and biological activity, Advanced Breast Cancer Therapies
Most-Cited Works
- → Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)(2010)261 cited
- → Intra-specific variation in resting metabolic rate in MF1 mice is not associated with membrane lipid desaturation in the liver(2007)25 cited
- → Supplementary Figure 3 from Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)(2023)
- → Supplementary Figures 8-12 from Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)(2023)
- → Supplementary Table 6 from Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)(2023)
- → Supplementary Table 5 from Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)(2023)
- → Supplementary Figure 5 from Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)(2023)
- → Supplementary Table 4 from Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)(2023)
- → Supplementary Figure 6 from Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)(2023)